Clinical Trial Update: Cangrelor Prasugrel Transition Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transitioning patients from cangrelor to prasugrel in coronary artery disease; the study is completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cangrelor (cangrelor)
• PRASUGREL (prasugrel)

Snippet

Sponsor: The Medicines Company | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-05-28